A Pfizer company, Hospira, recently announced that it is voluntarily recalling lots of sodium bicarbonate injectables. The recall comes in the middle of a large sodium bicarbonate shortage. Companies are currently attempting to increase the supply of the drug but the products are only slowly trickling into the marketplace.
Sodium bicarbonate is another word for baking soda. Sodium bicarbonate injections are used to treat a number of conditions, including diabetes, renal disease, circulatory problems, and other issues. Sodium bicarbonate injections can also be used to treat some drug intoxications.
The recall is due to microbial growth that was detected during a manufacturing simulation. This could mean that microorganisms are present in the drugs. Fortunately, none of the manufactured products were found to have any microorganisms, but the possibility of contamination does exist. Wholesalers and hospitals across the U.S. are affected, as well as in some other countries.
The sodium bicarbonate shortage is a serious situation. Emergency rooms are increasingly finding it difficult to obtain the drug, and few alternatives are available. One of the alternatives is also facing a shortage.
This drug company appears to have taken proactive steps when realizing there was a potential problem with one of its products. That is not always the case, especially for extremely popular and profitable drugs. Drug companies have been known to hide problems from consumers, which can lead to serious health problems and even death.
If you have been harmed because of a defective prescription drug, you should speak with an attorney. The attorneys at Kennedy Hodges have experience in prescription drug litigation and will be happy to provide you with a free consultation. Call them today at 855-947-0707 to schedule your consultation, or visit their Facebook page to learn more.